Council of Scientific and Industrial Research

Prachi Sinha

Sushil Kumar

Suman Preet Singh Khanuja

Mahendra Pandurang Darokar

Ajit Kumar Shasany

Madan Mohan Gupta

Vivek Kumar Gupta

Jai Shankar Arya

Monika Singh

Subhash Chandra Gupta

Sunil Balkrishna Mansinghka

Suresh Haribhau Dawle

Soumya Awasthi

Sweta Agarwal

Ram Kishore Verma

Tiruppadiripuliyur Ranganathan Santha Kumar

Nirmal Kumar Patra

Dharmendra Saikia

Sunita Dhawan

Suchi Srivastava

Krishna Kumar Agarwal

Ajit Kumar Shasney

Ateeque Ahmed

The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine distillate as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, drugs, therapeutic and nutraceutic agents, ions and similar molecules which are targeted to the living systems.

[object Object]

Use of bioactive fraction from cow urine distillate ('go-mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

A formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of thymol obtained from the plant , mint oil containing an appropriate amount of monoterpenes obtained from a hybrid of and , and conventional additives. A method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistance in a patient by administration of a therapeutically effective amount of the formulation.

Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

A formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of thymol obtained from the plant mint oil containing an appropriate amount of monoterpenes obtained from a hybrid of and and conventional additives. A method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistance in a patient by administration of a therapeutically effective amount of the formulation.

A pharmaceutical composition comprising an antibiotic and cow urine distillate in an amount effective to enhance antimicrobial effect of the antibiotic is disclosed. The antibiotic can be an antifungal agent. The antibiotic can be a quinolone or a fluoroquinolone. The antifungal agent can be azoles, clotrimazole, mystatin or amphotericin.

Pharmaceutical composition containing cow urine distillate and an antibiotic

Growing community of inventors

Lucknow, India

Prachi Sinha